Seeking Alpha

CNBC reports (video) an unusually high volume of call options in Pharmasset (VRUS +84.7%) were...

CNBC reports (video) an unusually high volume of call options in Pharmasset (VRUS +84.7%) were purchased just a few days before the buyout of the company by Gilead Sciences (GILD -9.7%). Analysts say the activity may get more than a passing glance look from regulators.
From other sites
Comments (4)
  • HiSpeed
    , contributor
    Comments (1212) | Send Message
     
    Congressional buyers?
    21 Nov 2011, 03:43 PM Reply Like
  • SogoTrade
    , contributor
    Comments (41) | Send Message
     
    The highest open interest as of today was 1154 Dec 80 calls. Doesn't seem that high to me.
    21 Nov 2011, 03:48 PM Reply Like
  • Rick Mortimer
    , contributor
    Comments (3) | Send Message
     
    No unusual volume the last 5 trading days. someone's missing something!
    21 Nov 2011, 03:53 PM Reply Like
  • TraderMark
    , contributor
    Comments (2422) | Send Message
     
    unless they were Congressman
    21 Nov 2011, 03:53 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs